AMLX

Amylyx Pharmaceuticals Inc. Common Stock (AMLX)

Stock · NASDAQ · Health Care

$34.74as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$14.06
Industry
Biotechnology: Pharmaceutical Preparations

Amylyx Pharmaceuticals Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • AMLX
    Amylyx Pharmaceuticals Inc. Common Stock
    $34.74
    ▼ 6.56%
    Market cap $2.24BP/E
  • KLRA
    Kailera Therapeutics Inc. Common Stock
    $16.26
    ▼ 12.25%
    Market cap $2.24BP/E
    $16.19$28.23
  • VERA
    Vera Therapeutics Inc. Class A Common Stock
    $34.19
    ▼ 1.18%
    Market cap $2.31BP/E
    $21.2$56.05
  • NUVB
    Nuvation Bio Inc. Class A Common Stock
    $6.67
    ▼ 4.65%
    Market cap $2.14BP/E
    $2.87$9.75
  • PGEN
    Precigen Inc. Common Stock
    $6.94
    ▼ 3.55%
    Market cap $2.36BP/E
    $2.99$7.72
  • MLYS
    Mineralys Therapeutics Inc. Common Stock
    $25.59
    ▼ 1.61%
    Market cap $2.13BP/E
    $14.94$47.65
  • NKTR
    Nektar Therapeutics Common Stock
    $72.57
    ▼ 2.66%
    Market cap $2.38BP/E
    $27.87$109

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
112.87M
Total value held
$1.56B
Institutional holders
167
Top holders this quarter
  • Unknown16.63M
  • Unknown8.83M
  • Unknown8.28M
  • Unknown6.24M
  • Unknown5.65M
  • Unknown4.99M
  • Unknown4.35M
  • Unknown4.14M
  • Unknown3.56M
  • Unknown3.19M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.